The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats.

Redox Biol · 2017 · PMC5491464 · PMID 28667906

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The expression of NADPH oxidase isoform Nox1 was not changed in aorta of ZDF rats but showed a trend for decrease by 20–25% under SGLT2i treatment (not shown).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.